Glucotrack, Inc. (GCTK) › Total LiabilitiesGlucotrack, Inc. (GCTK) — Total LiabilitiesAnnual figures by period end, from SEC filings.2010-12-31: $1.17M2011-12-31: $1.21M2012-12-31: $1.32M2013-12-31: $9.46M2014-12-31: $3.43M2015-12-31: $2.17M2016-12-31: $3.37M2017-12-31: $4.82M2018-12-31: $3.56M2019-12-31: $2.51M2020-12-31: $1.62M2021-12-31: $1.11M2022-12-31: $1.21M2023-12-31: $1.71M2024-12-31: $18.93M2025-12-31: $5.01M$5.01M2010-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$5.01M-73.5%2026-03-30Balance as of period end2024-12-31$18.93M+1008.4%2026-03-30Balance as of period end2023-12-31$1.71M+41.4%2025-03-31Balance as of period end2022-12-31$1.21M+8.8%2024-03-28Balance as of period end2021-12-31$1.11M-31.7%2023-03-31Balance as of period end2020-12-31$1.62M-35.2%2022-03-31Balance as of period end2019-12-31$2.51M-29.6%2021-04-13Balance as of period end2018-12-31$3.56M-26.1%2020-04-14Balance as of period end2017-12-31$4.82M+43.1%2019-04-15Balance as of period end2016-12-31$3.37M+55.5%2018-03-30Balance as of period end2015-12-31$2.17M-36.9%2017-03-31Balance as of period end2014-12-31$3.43M-63.7%2016-03-30Balance as of period end2013-12-31$9.46M+617.7%2015-03-31Balance as of period end2012-12-31$1.32M+8.5%2014-03-28Balance as of period end2011-12-31$1.21M+3.6%2013-04-01Balance as of period end2010-12-31$1.17M—2012-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)